RetractedArticleOncology letters2019

miR-200b and miR-200c co-contribute to the cisplatin sensitivity of ovarian cancer cells by targeting DNA methyltransferases.

Jue Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.